These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9368927)

  • 1. Calcium dobesilate-induced agranulocytosis.
    García Benayas E; García Díaz B; Pérez G
    Pharm World Sci; 1997 Oct; 19(5):251-2. PubMed ID: 9368927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agranulocytosis associated with calcium dobesilate clinical course and risk estimation with the case-control and the case-population approaches.
    Ibáñez L; Ballarín E; Vidal X; Laporte JR
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):763-7. PubMed ID: 11214789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium dobesilate-induced agranulocytosis.
    Duggal L; Thukral R; Kumar S
    J Assoc Physicians India; 2005 Apr; 53():320-1. PubMed ID: 15987021
    [No Abstract]   [Full Text] [Related]  

  • 4. [Agranulocytosis induced by calcium dobesilate].
    Cladera Serra A; Blasco Mascaró I; Oliva Berini E; Ramos Díaz F
    Med Clin (Barc); 1995 Oct; 105(14):558-9. PubMed ID: 8523936
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk of drug-induced agranulocytosis: the case of calcium dobesilate.
    Zapater P; Horga JF; García A
    Eur J Clin Pharmacol; 2003 Mar; 58(11):767-72. PubMed ID: 12634984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
    Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
    Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent agranulocytosis after taking calcium dobesilate].
    Kulessa W; Becker EW; Berg PA
    Dtsch Med Wochenschr; 1992 Mar; 117(10):372-4. PubMed ID: 1544335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of drug-induced agranulocytosis: an approximation to risk analysis arising from spontaneous notification of agranulocytosis cases among patients treated with calcium dobesilate].
    Zapater Hernández P; Horga de la Parte JF; García AG
    An Med Interna; 2002 Jun; 19(6):275-82. PubMed ID: 12152385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.
    Haritoglou C; Gerss J; Sauerland C; Kampik A; Ulbig MW;
    Lancet; 2009 Apr; 373(9672):1364-71. PubMed ID: 19376452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium dobesilate: neutropenia.
    Prescrire Int; 2010 Oct; 19(109):218. PubMed ID: 21188809
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced fever: a clinical report and challenge test with calcium dobesilate.
    Puyana J; Fraj J; De La Hoz F; Davila I; Vergara C; Cuesta J
    Int Arch Allergy Appl Immunol; 1990; 92(4):364-5. PubMed ID: 2083972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dobesilate-induced serious neutropenia].
    Burgan F; Montastruc JL; Bagheri H
    Presse Med; 2009 May; 38(5):846-8. PubMed ID: 19278816
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R; Chiavaroli C; Garay RP; Hannaert P
    Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial.
    Schram MT; Stam F; de Jongh RT; de Vries G; van Dijk RA; Serné EH; Lampe D; Nanayakkara PW; Tushuizen ME; Scheffer PG; Schalkwijk CG; Kamper AM; Stehouwer CD
    Atherosclerosis; 2003 Sep; 170(1):59-72. PubMed ID: 12957683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium dobesilate in the treatment of diabetic retinopathy.
    Garay RP; Hannaert P; Chiavaroli C
    Treat Endocrinol; 2005; 4(4):221-32. PubMed ID: 16053339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium Dobesilate Prevents Neurodegeneration and Vascular Leakage in Experimental Diabetes.
    Solà-Adell C; Bogdanov P; Hernández C; Sampedro J; Valeri M; Garcia-Ramirez M; Pasquali C; Simó R
    Curr Eye Res; 2017 Sep; 42(9):1273-1286. PubMed ID: 28574750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The plasma levels of endothelin in diabetic retinopathy and their changes after treatment with doxium].
    Zhong H; Guo L
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):56-8. PubMed ID: 9868029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.